BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8020659)

  • 1. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat.
    Wallace JL; Reuter B; Cicala C; McKnight W; Grisham MB; Cirino G
    Gastroenterology; 1994 Jul; 107(1):173-9. PubMed ID: 8020659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diclofenac derivative without ulcerogenic properties.
    Wallace JL; Reuter B; Cicala C; McKnight W; Grisham M; Cirino G
    Eur J Pharmacol; 1994 May; 257(3):249-55. PubMed ID: 8088345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical endoscopic evaluation of the gastroduodenal tolerance to (R)- ketoprofen, (R)- flurbiprofen, racemic ketoprofen, and paracetamol: a randomized, single-blind, placebo-controlled trial.
    Jerussi TP; Caubet JF; McCray JE; Handley DA
    J Clin Pharmacol; 1998 Feb; 38(2S):19S-24S. PubMed ID: 9549655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy?
    Wallace JL; McCafferty DM; Carter L; McKnight W; Argentieri D
    Gastroenterology; 1993 Dec; 105(6):1630-6. PubMed ID: 8253339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some new 2-(2-fluoro-4-biphenylyl)propionic acid derivatives as potential anti-inflammatory agents.
    Amir M; Kumar S
    Pharmazie; 2005 Mar; 60(3):175-80. PubMed ID: 15801668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester].
    Wallace JL; Muscará MN; de Nucci G; Zamuner S; Cirino G; del Soldato P; Ongini E
    J Pharmacol Exp Ther; 2004 May; 309(2):626-33. PubMed ID: 14755007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.
    Somasundaram S; Rafi S; Jacob M; Sigthorsson G; Mahmud T; Sherwood R; Price AB; Macpherson A; Scott D; Wrigglesworth JM; Bjarnason I
    Gut; 1997 May; 40(5):608-13. PubMed ID: 9203938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses.
    Holzer P; Jocic M; Cabré F; Mauléon D
    Inflamm Res; 2001 Dec; 50(12):602-8. PubMed ID: 11822786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties.
    Cirino G; Wheeler-Jones CP; Wallace JL; Del Soldato P; Baydoun AR
    Br J Pharmacol; 1996 Apr; 117(7):1421-6. PubMed ID: 8730734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity.
    Wallace JL; Reuter BK; Cirino G
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S40-4. PubMed ID: 7881018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
    Wallace JL; Caliendo G; Santagada V; Cirino G; Fiorucci S
    Gastroenterology; 2007 Jan; 132(1):261-71. PubMed ID: 17241876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the nonsteroidal antiinflammatory drug flurbiprofen and its nitric oxide-releasing derivative, nitroflurbiprofen, on prostaglandin E(2), interleukin-1beta, and nitric oxide synthesis by activated microglia.
    Ajmone-Cat MA; Nicolini A; Minghetti L
    J Neurosci Res; 2001 Nov; 66(4):715-22. PubMed ID: 11746392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
    Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
    Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity.
    Yamakawa N; Suemasu S; Okamoto Y; Tanaka K; Ishihara T; Asano T; Miyata K; Otsuka M; Mizushima T
    J Med Chem; 2012 Jun; 55(11):5143-50. PubMed ID: 22404396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects and metabolic fate of nitroflurbiprofen in healthy volunteers.
    Zacharowski P; Zacharowski K; Donnellan C; Johnston A; Vojnovic I; Forte P; Del Soldato P; Benjamin N; O'Byrne S
    Clin Pharmacol Ther; 2004 Oct; 76(4):350-8. PubMed ID: 15470334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
    Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
    J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of NSAIDs on bladder function in normal and cystitis rats: a comparison study of aspirin, indomethacin, and ketoprofen.
    Takagi-Matsumoto H; Ng B; Tsukimi Y; Tajimi M
    J Pharmacol Sci; 2004 Aug; 95(4):458-65. PubMed ID: 15322343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
    Chan CC; Boyce S; Brideau C; Ford-Hutchinson AW; Gordon R; Guay D; Hill RG; Li CS; Mancini J; Penneton M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1531-7. PubMed ID: 7562530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoprotective effect of a nitric oxide donor drug on gastric mucous membrane of rats treated with ketoprofen, a non-steroidal anti-inflammatory drug.
    Villa AL; Reginaldo C; Viaro F; Ramalho F; Campos AD; Evora PR
    Arq Gastroenterol; 2006; 43(3):233-7. PubMed ID: 17160241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.